0.00
price down icon100.00%   -11.19
after-market Handel nachbörslich: 11.25 11.25 +
loading
Schlusskurs vom Vortag:
$11.19
Offen:
$0
24-Stunden-Volumen:
0
Relative Volume:
0.00
Marktkapitalisierung:
$121.08M
Einnahmen:
-
Nettoeinkommen (Verlust:
$1.45M
KGV:
0.00
EPS:
-0.7191
Netto-Cashflow:
$-705.90K
1W Leistung:
-100.00%
1M Leistung:
-100.00%
6M Leistung:
-100.00%
1J Leistung:
-100.00%
1-Tages-Spanne:
Value
$0.00
$0.00
1-Wochen-Bereich:
Value
$0.00
$11.23
52-Wochen-Spanne:
Value
$0.00
$11.24

Keen Vision Acquisition Corp Stock (KVAC) Company Profile

Name
Firmenname
Keen Vision Acquisition Corp
Name
Telefon
(203) 609-1394
Name
Adresse
37 GREENBRIAR DRIVE, SUMMIT
Name
Mitarbeiter
0
Name
Twitter
Name
Nächster Verdiensttermin
2024-11-11
Name
Neueste SEC-Einreichungen
Name
KVAC's Discussions on Twitter

Vergleichen Sie KVAC mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Shell Companies icon
KVAC
Keen Vision Acquisition Corp
0.00 121.08M 0 1.45M -705.90K -0.7191
Shell Companies icon
LION
Lionsgate Studios Corp
7.11 2.06B 3.13B 50.80M 555.00M 0.1772
Shell Companies icon
AACT
Ares Acquisition Corporation Ii
11.14 696.88M 0 16.92M -1.35M 0.29
Shell Companies icon
ANSC
Agriculture Natural Solutions Acquisition Corp
10.66 459.71M 0 1.30M 0 0.0301
Shell Companies icon
AAM
Aa Mission Acquisition Corp
10.27 451.17M 0 0 0 0.00
Shell Companies icon
EQV
Eqv Ventures Acquisition Corp
10.09 449.74M 0 0 0 0.00

Keen Vision Acquisition Corp Aktie (KVAC) Neueste Nachrichten

pulisher
Apr 02, 2025

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PIK, SMAR, KVAC on Behalf of Shareholders - ACCESS Newswire

Apr 02, 2025
pulisher
Apr 01, 2025

Medera Presented Updated Results from First-In-Human Gene Therapy Trial for Heart Failure with Preserved Ejection Fraction at 2025 HFpEF Summit - Yahoo Finance

Apr 01, 2025
pulisher
Mar 31, 2025

Keen Vision Acquisition Co. (NASDAQ:KVAC) Sees Significant Growth in Short Interest - MarketBeat

Mar 31, 2025
pulisher
Mar 28, 2025

KVAC stock soars to all-time high, touches $11.25 By Investing.com - Investing.com Canada

Mar 28, 2025
pulisher
Mar 28, 2025

Keen Vision Acquisition Corp. Secures Funding to Extend Merger Deadline By Investing.com - Investing.com Australia

Mar 28, 2025
pulisher
Mar 28, 2025

KVAC stock soars to all-time high, touches $11.25 - Investing.com

Mar 28, 2025
pulisher
Mar 28, 2025

Keen Vision Acquisition Corp. Secures Funding to Extend Merger Deadline - Investing.com India

Mar 28, 2025
pulisher
Mar 26, 2025

Mizuho Securities USA LLC Has $11.10 Million Position in Keen Vision Acquisition Co. (NASDAQ:KVAC) - MarketBeat

Mar 26, 2025
pulisher
Mar 25, 2025

Keen Vision Acquisition (NASDAQ:KVAC) Trading 0.2% HigherStill a Buy? - MarketBeat

Mar 25, 2025
pulisher
Mar 22, 2025

Keen Vision Acquisition (NASDAQ:KVAC) Shares Up 0.2% – What’s Next? - Defense World

Mar 22, 2025
pulisher
Mar 21, 2025

KVAC stock soars to all-time high of $11.19 amid market optimism - Investing.com Australia

Mar 21, 2025
pulisher
Mar 21, 2025

KVAC stock soars to all-time high of $11.19 amid market optimism By Investing.com - Investing.com South Africa

Mar 21, 2025
pulisher
Mar 20, 2025

Medera Receives DSMB Clearance to Initiate Phase 2 Portion of MUSIC-HFrEF Phase 1b/2 Trial for SRD-001 Gene Therapy in Heart Failure with Reduced Ejection Fraction - GlobeNewswire

Mar 20, 2025
pulisher
Mar 20, 2025

Medera Receives DSMB Clearance to Initiate Phase 2 Portion - GlobeNewswire

Mar 20, 2025
pulisher
Mar 18, 2025

STOCKHOLDER ALERT: The M&A Class Action Firm Continues To Investigate The MergerNHHS, KVAC, AMPS, AVTE - PR Newswire

Mar 18, 2025
pulisher
Mar 17, 2025

$HAREHOLDER ALERT: The M&A Class Action Firm Continues To Investigate The Merger – NHHS, KVAC, AMPS, AVTE - GlobeNewswire Inc.

Mar 17, 2025
pulisher
Mar 11, 2025

Medera Completes Patient Dosing for Heart Failure Treatment - Yahoo Finance

Mar 11, 2025
pulisher
Mar 11, 2025

Medera completes patient dosing in Phase 1/2a MUSIC-HFrEF - TipRanks

Mar 11, 2025
pulisher
Mar 11, 2025

Medera Completes Patient Dosing in Phase 1/2a MUSIC-HFrEF - GlobeNewswire

Mar 11, 2025
pulisher
Mar 11, 2025

Medera Completes Patient Dosing in Phase 1/2a MUSIC-HFrEF Trial of SRD-001 Gene Therapy for Heart Failure with Reduced Ejection Fraction - Yahoo Finance

Mar 11, 2025
pulisher
Mar 10, 2025

KVAC stock soars to all-time high, reaching $11.18 By Investing.com - Investing.com Australia

Mar 10, 2025
pulisher
Mar 10, 2025

KVAC stock soars to all-time high, reaching $11.18 - Investing.com

Mar 10, 2025
pulisher
Mar 07, 2025

Keen Vision Acquisition Corp. SEC 10-K Report - TradingView

Mar 07, 2025
pulisher
Mar 04, 2025

Keen Vision Acquisition Co. (NASDAQ:KVAC) Short Interest Update - MarketBeat

Mar 04, 2025
pulisher
Feb 28, 2025

BridgeBio's cancer spinout backs SPAC as path to Nasdaq - Fierce Biotech

Feb 28, 2025
pulisher
Feb 27, 2025

Keen Vision Acquisition Corp. extends business combination period By Investing.com - Investing.com South Africa

Feb 27, 2025
pulisher
Feb 27, 2025

Keen Vision Acquisition Corp. extends business combination period - Investing.com

Feb 27, 2025
pulisher
Feb 26, 2025

KVAC stock soars to all-time high of $11.15 amid market optimism - Investing.com Canada

Feb 26, 2025
pulisher
Feb 26, 2025

KVAC stock soars to all-time high of $11.15 amid market optimism By Investing.com - Investing.com South Africa

Feb 26, 2025
pulisher
Feb 26, 2025

Wolverine Asset Management LLC Has $6.84 Million Stock Holdings in Keen Vision Acquisition Co. (NASDAQ:KVAC) - MarketBeat

Feb 26, 2025
pulisher
Feb 14, 2025

KVAC stock soars to all-time high of $11.12 amid market optimism - Investing.com Nigeria

Feb 14, 2025
pulisher
Feb 13, 2025

KVAC stock soars to all-time high of $11.12 amid market optimism By Investing.com - Investing.com South Africa

Feb 13, 2025
pulisher
Feb 11, 2025

Form 425 Medera Inc. Filed by: Medera Inc. - StreetInsider

Feb 11, 2025
pulisher
Feb 10, 2025

Medera’s Novoheart Expands Human Cardiac Research with - GlobeNewswire

Feb 10, 2025
pulisher
Feb 10, 2025

Medera’s Novoheart Expands Human Cardiac Research with CTScreen™ Installation at University Medical Center, Utrecht - Yahoo Finance

Feb 10, 2025

Finanzdaten der Keen Vision Acquisition Corp-Aktie (KVAC)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
shell_companies ALF
$10.26
price down icon 0.31%
$10.30
price down icon 0.07%
$9.95
price down icon 0.50%
$10.69
price down icon 1.02%
$10.98
price up icon 0.09%
shell_companies EQV
$10.09
price down icon 0.20%
Kapitalisierung:     |  Volumen (24h):